Torez 10/10 (Ezetimibe 10 mg / Atorvastatin 10 mg, Unipharm, 30 Coated Tablets) is a dual-action lipid-lowering combination medication manufactured by Unipharm. By combining ezetimibe and atorvastatin, Torez 10/10 reduces cholesterol through two mechanisms: inhibiting cholesterol absorption in the intestine and suppressing endogenous cholesterol synthesis in the liver.

Indications: Torez 10/10 is indicated for:

• Treatment of primary hypercholesterolemia (familial and non-familial) and mixed hyperlipidemia

• Reduction of elevated total cholesterol, LDL-C, triglycerides, and apolipoprotein B

• Prevention of cardiovascular events (myocardial infarction, stroke, revascularization procedures) in patients with coronary heart disease

Reasons for Use:

• Inadequate LDL-C reduction with statin monotherapy alone

• Elevated risk of atherosclerosis and major cardiovascular conditions

• Clinical need for intensive cholesterol management to reach target lipid goals

• Physician recommendation for dual lipid-lowering combination therapy

Key Features:

• Complementary active ingredients: Ezetimibe 10 mg + Atorvastatin 10 mg

• Synergistic action for enhanced LDL cholesterol lowering

• Film-coated tablets for convenient daily oral administration

• Manufactured by Unipharm

• Standard 30-tablet pack (1-month supply)

Dosage Form: Torez 10/10 — Coated tablets (pack of 30 tablets).

Manufacturer: Unipharm.

Active Ingredients (Per Tablet):

• Ezetimibe — 10 mg

• Atorvastatin (as Calcium Trihydrate) — 10 mg

#Torez #Torez1010 #Ezetimibe #Atorvastatin #Unipharm #LipidLowering #CholesterolManagement #CardiovascularHealth #IsraeliPharmacy #MedsFromIsrael